Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

Background. Identifying diagnostic and prognostic biomarkers that could be targeted in the therapy of pancreatic cancer is essential. Objective. Investigations were conducted with respect to plasma miRNA (miR-21, miR-210, miR-155, miR-196a, miR-20a, and miR-25) expression and clinicopathologic facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qi, Xu, Changqing, Yuan, Wei, Wang, Chengfeng, Zhao, Ping, Chen, Lianzhen, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390608/
https://www.ncbi.nlm.nih.gov/pubmed/28466015
http://dx.doi.org/10.1155/2017/6495867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390608/
https://www.ncbi.nlm.nih.gov/pubmed/28466015
http://dx.doi.org/10.1155/2017/6495867

Ejemplares similares